【参考文献】 1.Manicourt DH,Azria M,Mindeholm L,Thonar EJ,Devogelaer JP.Oral salmon calcitonin reduce Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 2006 Oct;54(10):3205-11 2.Garnero P,Charni N,Juillet F,Conrozier T,Vigno E Increased urinary type II collagen helical and telopeptide levels are independently associated with a rapidly destructive hip.osteoarthritis. Ann Rheum Dis. 2006 Dec;65(12):1639-44 3.Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY.Osteoarth- ritis, magnetic resonance imaging,and biochemical markers: a one year prospective study.Ann Rheum Dis. 2006 Aug;65(8):1050-4. 4.Manicourt DH,Bevilacqua M,Righini V,Famaey JP,DevogelaerJP. Comparative effect of nimesulide andibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D.2005;6(5):261-71. 5. Alexandersen P,Karsdal MA, Qvist P, Reginster JY, Christiansen C.: Strontium renelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone. 2007;40(1):218-22. 6. Landewé RB, Geusens P, van der Heijde DM, Boers M, van der Linden SJ, Garnero P.: Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis. Ann Rheum Dis. 2006 Jan; 65(1):40-4. Epub 2005 Aug 26. 7.Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ,Garnero P, Hellio Le Graverand MP, Degroot J, Slagboom PE.:Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.Ann Rheum Dis. 2006 Mar;65(3):360-5. 8. Bagger YZ, Tankó LB, Alexandersen P, Karsdal MA, Olson M,Mindeholm L, Azria M, Christiansen C.: Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005 Sep;37(3):425-30.